chrisvoncsefalvay/vaers-outcomes huggingface dataset:
TIGHTNESS IN CHEST; HEART RATE SPIKE; HEADACHES; ACHINESS THROUGHOUT BODY AND BODY HURT; FEVER; DIZZINESS; CHILLS; FELT TIRED AND FATIGUED; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: endometriosis, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811 expiry: UNKNOWN) dose was not reported, administered on 28-OCT-2021 20:00 for prophylactic vaccination. Concomitant medications included topiramate for drug used for unknown indication.  On 28-OCT-2021, the patient experienced felt tired and fatigued. On 29-OCT-2021, the patient experienced achiness throughout body and body hurt. On 29-OCT-2021, the patient experienced dizziness. On 29-OCT-2021, the patient experienced chills. On 29-OCT-2021, the patient experienced fever. Laboratory data included: Body temperature (NR: not provided) 101F to 102F. On 30-OCT-2021, the patient experienced tightness in chest. On 30-OCT-2021, the patient experienced heart rate spike. On 30-OCT-2021, the patient experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from achiness throughout body and body hurt, heart rate spike, dizziness, chills, and felt tired and fatigued, and fever on 30-OCT-2021, and had not recovered from headaches, and tightness in chest. This report was non-serious.
Information has been received from a registered nurse concerning a 2 year old male who was vaccinated with a dose of Varivax. "Last week", on approximately 09-MAY-2006 the patient developed chickenpox., Unspecified medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Almost exactly twelve hours after shot I developed excruciating pain in my arm and lower back. I also had mild diarrhea,  The pain took about a week to subside but the gastric problem went down hill. I went to the gastric doc and told him my gut was reacting to the shot and he didn't believe me.  We did a endoscopy, checked for parasites, infections, food allergies, stool samples twice. All tests came back with a happy face.  I was given a variety of meds.. none worked. so after about four months of misery I found a new doc who looked at all the tests and said Lymphasitic colitis (not sure of spelling) caused by numerous things none applied except AN IMUNE RESPONSE. TO A VIRUS............
At around 10pm I began with nausea and headache. On April 14 the 1st dose shot. The following day April 15 I started with fevers, chills, body aches, tiredness and pain in my neck. On April 16 I had minor diarrhea.
Pt fell alseep on way home from clinic & slept until 954PM when awakened screamed & seemed to have trouble breathing; pt body was red all over & stiff; When pt tried to breathe became very pale; t102.4 R; parents called 911;
pt. recvd. 1st dose of Hep B vax 20AUG89. On 21AUG89 pt. exp. body aches,nausea,pain behind eyes,rash,hot flashes,& T-98.8.
Information has been received from a registered nurse concerning a child who was vaccinated with a dose of varicella virus vaccine. Subsequently, the patient developed a mild case of chicken pox. No further information was provided. No product quality complaint was involved. It was also reported that another child was vaccinated with a dose of varicella virus vaccine live and developed a severe case of chicken pox (WAES0404USA02368). Additional information has been requested.
Patient complaint that she started seeing a growing mass on the injection site approximately 45 days after receiving vaccine.
Pt. states that after receiving the 1st dose of Pfizer 06/30/2021, started experiencing symptoms immediately of pain in the left arm continuing 3 months later. No noted Primary visit.
Hives from head to toe. Oral antihistamine taken for treatment. Time course of approximately one week.
Raised bumps that feel warm to the touch and itchy with occasional mild pain surrounded by a  3inx3in red rash.
Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Vomiting) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 628A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VOMITING (Vomiting). At the time of the report, VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-063305 (E2B Linked Report).; Sender's Comments:  MOD21-063305:
7/1/99, child recv rota shield; 7/16 father devel bowel obstruction & hosp; mom attributed the father's bowel obstruction to rota shield from exposure to pt
fever for 5 days 99.5 - 101.9, nausua, headache,feeling week tingling in legs
DRY THROAT; DIARRHOEA; VOMITING; This spontaneous report received from a patient concerned a 38 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: aspirin allergy. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1808609, expiry: unknown) dose was not reported, 1 total administered on 07-APR-2021 on left arm for prophylactic vaccination. It was unknown if patient experienced any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient later received non-company suspect vaccine tozinameran (Pfizer) (dose number in series 2) (form of admin, route of admin were not reported, batch number: FD7218 expiry: unknown) dose was not reported, administered on 18-DEC-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On 16-MAR-2022, the patient experienced symptoms like diarrhoea and vomiting (dose number in series 2). On an unspecified date, patient experienced dry throat (dose number in series 2). The patient did not undergo any Covid-19 test. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from diarrhoea, dry throat and vomiting. This report was non-serious.
He got his vaccine, immediately afterwards had typical soreness at the injection site.  He didn't notice anything else until about mid afternoon when he was feeling some muscle fatigue, soreness.  Other than that he had not noticed any other reactions at all until he started getting read for bit around 9:30 when he started to shiver and shake.  He went to bed and about 2 hours later he woke up with a headache and could tell that his heart rate was pretty fast.  He checked his pulse and oxygen and his pulse was around 115, and his oxygen around 95.  He got up and tried to calm himself down, sat outside and tried to somehow relax himself for about an hour. It went down to about 100 BPM, and then he went back to bed and finally went to sleep.  When he woke up the next day it was in the 60's and the oxygen in the mid 90's.  Today, he is back to normal although his arm is still sore.    Had COVID vaccines with the only expected reactions and also with a flu vaccine, just a sore arm.
Pt recvd 2 doses of Engerix-B & 3 hrs p/2nd dose arm blew-up, induration of 4-5inches up @ the center @ needle site; also exp vesicle formation 5mm; rt arm swelled going down to hands & fingers; itching of throat & allover but no hives;
At the end of the COVID vaccine clinic on 11/11/2021 at approximately 1715 I, RN Nurse Manager of the clinic realized that additional doses of the COVID clinic would need to be mixed and drawn up for the remaining patients on the schedule. I went into the medication room to mix a vial of the COVID vaccine with normal saline as I had been taught to do earlier in the day with Pharmacist. I opened the red bag of supplies to mix up the vaccine and only found one vial in the bag with a salmon colored top. Remembering that that the vaccine came in a vial with an orange top I believed this to be the vaccine and was looking for the diluent. Unable to locate some I called pharmacist and she informed me that I was fine to use normal saline from another source to mix the vaccine. I located another source of normal saline within the clinic and used it to mix 1.3ml of normal saline into the vial. After following the mixing instructions of inverting the initial vial 10x, added the diluent, removed 1.3ml of air, and then inverted the vial 10x to mix, I then drew up multiple syringes of 0.2ml RN and MA each took two syringes to vaccinators who were waiting to administer the vaccine to patients. approximately 10-15 minutes later another HCP and I called pharmacist to ensure I knew how to properly dispose of the unused vaccine. It was during this conversation that I realized I had not used the COVID vaccine vial but had used the diluent vial and had mixed additional NACL into the diluent vial. I immediately asked who had received the last 4 doses, 3 of those patients were still in the building and 1 patient had left. I notified the parents of the 3 patients who were still on the premises of the error that was made and apologized. I then asked if they would still like the patient to receive the COVID vaccine tonight and the parents agreed. Those 3 patients each received a dose after I went back into the med room and correctly mixed the vaccine. The patients remained under observation for 15 minutes and were then discharged. None of these patients experienced any negative effects while under observation. A phone call and message was left/sent to the parent of the 4th patient that night and the following morning another phone call was placed to the patient's father and the situation explained. Father agreed to bring the patient in on the following Monday in order to receive the COVID vaccine.
Mother called the Health Department on 09/26/2013 to report her daughter had a vaccine reaction on September 16, 2013 three weeks post IPV vaccine. Her daughter woke on 09/16/2013 with pain and "inflammation on the neck and surrounding her left ear. Child was taken to a pediatrician and treated with Cefadroxil 500mg BID for 10 days. Mother reports a "strep test" and ear exam were negative. the inflammation resolved within 4 days.
Chills, fever (102.8), aches, headache, fatigue - sick in bed 24 hrs, nausea. Treated with acetaminophen. Had low grade fever an additional 24 hrs. Didn't feel 100% for 3 days from onset.
On Sat (11/14/09), pt experienced numbness in middle toe on left foot. On Mon (11/16/09), numbness spread to rear of foot (her heal).  Pt has numbness only on her left foot and only when not moving and feels like needles are poking her.  Numbness goes away when moving. On 11/18/2009 pt's glands started to swell up around her neck and glands. Pain is now radiating to her arm and arm pits.  She is using heat packs and taking pain medication.  She has an appointment scheduled with her physician.
INCREASED HEART RATE; RED EYES; SEVERE CHILLS; FEVER; This spontaneous report received from a patient concerned a 30 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included immunodeficient, recurrent infections, chronic inflammation, asthma, cat allergy, dog allergy, and seasonal allergies. The patient experienced drug allergy when treated with azithromycin non-company, and sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. Concomitant medications included ibuprofen for fever. On 12-MAR-2021, the subject experienced increased heart rate. On 12-MAR-2021, the subject experienced red eyes. On 12-MAR-2021, the subject experienced severe chills. On 12-MAR-2021, the subject experienced fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102.7 (not reported), 101.6 (not reported), 102.3-102.5 (not reported), 101.7 (not reported), and Heart rate increased (NR: not provided) over 100 (not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from red eyes, severe chills, fever, and increased heart rate. This report was non-serious.; Sender's Comments: V0: Medical Assessment Comment is not required per standard   procedure as the case includes non-serious event.
Received IM injection of influenza vaccine at 0930 on October 19, 2004. About 45 minutes later, developed pain at injection site which spread to arms, legs and cheeks. No wheezing or respiratory difficulties. Had mild-moderate tenderness of large muscles (thighs, upper arms) as well as cheeks of face. Subsided about 30 minutes after returning to our clinic. Treated with ibuprofen; but symptoms seemed to subside before the ibuprofen would have take effect. All symptoms gone in 90 min.
developed two blood clots in his right calf; pain in his leg; This is a spontaneous report from a contactable consumer reporting for himself. A 70-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EN9581/expiration date: not provided), via an unspecified route of administration, on 04Feb2021 (at the age of 70 years old) as a single dose for COVID-19 IMMUNIZATION. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL3249/expiration date: not provided), via an unspecified route of administration, on 15Jan2021 (at the age of 70 years old) as a single dose for COVID-19 IMMUNIZATION. Relevant medical history included was not provided. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN), meloxicam, an allergy medication and anti-depressants. On 19Feb2021, the patient reported that he developed two blood clots in his right calf, one towards his ankle and one towards his knee and pain in his leg which required hospitalization on 22Feb2021. The patient was discharged on the same day, 22Feb2021. Relevant lab data included: blood test on 22Feb2021 were done to determine what medication to put him on. The results of the blood test was unknown. Treatment received for the event thrombosis included abixaban (ELIQUIS) tablets as a blood thinner. The patient reported he never had blood clots in his life. The outcome of the events thrombosis and pain in leg was unknown.
Sore Arm at injection site; slight clamminess on forehead; This is a spontaneous report from a contactable consumer. A 62-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9809), via an unspecified route of administration in arm left on 15Feb2021 at 08:45 AM (at the age of 61-year-old) as a 1st dose, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included methotrexate. It was reported that, patient did not receive any other vaccine in fourweeks. No covid prior vaccination and no covid tested post vaccination. The patient experienced, sore arm at injection site and slight clamminess on forehead. The outcome of the events was unknown.
Patient reports a history of eczema, and was diagnosed between the ages of 7-13. Symptoms controlled with Benadryl and creams. She never had any facial involvement until she received AVA. Denies any problems with other vaccines. She stated that approximately one week post AVA # 1 she noticed that her face was dry, irritated and swollen. She denied any new creams or products. The symptoms started to clear when she received AVA # 2 on 13 Mar. She reported that within 4 days after vaccination the facial symptoms reoccurred and persisted for about 3 wks  Symptoms: RASH&OTH NONSPEC SKIN ERUPTION(R21), PRURITUS, UNSPECIFIED(L299).
A little less than 3 hours after getting the shot, I noticed the injection site was getting very sore. Within about a half hour of first noticing it, that entire muscle was aching a lot. It?s now 4:50pm and it hurts to lift my arm, reach for anything, I can even feel it just by typing this out. I?ve also noticed I?m pretty tired, my joints feel very achey like when I have a cold, and I?m incredibly thirsty. The pain in the muscle at injection site is by far the worst symptom though. It?s extremely painful. I did not expect that since it didn?t hurt when getting the actual shot. Took my temp and it?s normal. The aching joints are far less painful than my arm, but are an issue nonetheless. Had I known this would happen beforehand, I would still get the shot, so as long as it doesn?t get a lot worse or something else haplens, all in all I?d have to say it was worth it.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 035C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021 at 3:04 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Nov-2021 at 3:04 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 86.23 for dose administered on 03-NOV-2021.  Concomitant products were not provided.  On 03-Nov-2021, Excursion time was 10:00 A.M., temperature was 35 degrees Fahrenheit, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 05-Oct-2021, vial was moved to clinic on 03-Nov-2021. 20 vials were sent to clinic. Vaccine BUD date was 05-Nov-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
Headaches started approx 4-5 days post second dose of Pfizer vaccination - comes and goes - pain level 2-4 of 10
A report was received from a health care professional concerning a 65 year old male vaccinee. The vaccinee has a past medical history of gastric banding, and a current history of coronary artery disease,d congestive cardiac failure, Type II Diabetes mellitus and kidney stones. Concomitant medications included Altace, Coreg, Elavil, Keflex, Lasix and Potassium. The vaccinee had received Influenza vaccine in the past with on adverse effects. On 10/17/06 the vaccine received influenza vaccine (Brand unspecified) in his right shoulder and pneumococcal 23 v polysaccharide vaccine in his left shoulder. Within 3 hours the vaccinee developed localised pain in his left arm and shivering. An hour later he had sluggish speech and was confused. He was taken to the ER with a systolic blood pressure of 129 and saturated oxygen at 100%. He was confused, had slurred speech and severe shivering and was treated with oxygen and a warm blanket. The vaccinee had severe left shoulder pain, especially with movement, with a heavy sensation in the arm. The physician indicated that blood test including cardiac enzymes were performed, and that the events did not appear to be cardiac related. The vaccinee was not able to raise his arm but was able to move his fingers, there was severe pain with passive movement of the arm. Additional vital signs included systolic blood pressure 109, pulse 55, temp 97.1. Hospital transfer for further evaluation, treatment and possible hospital admission were being considered at the time of the report. The reporter considered the events to be serious, immediately life threatening and in important medical event (OMIC).
Piercing headaches, dizziness. I just sit down until it's gone, 2-3 times a day.
Palpitations, fluttering, tachycardia, dyspnea, brain fog, chest tightness & fatigue.
Infection- antibiotics(keflex), vaccinated area is hard, red, swollen, painful, and slightly bruised
This case was reported by a consumer and described the occurrence of Guillain Barre Syndrome in a male subject of unspecified age who was vaccinated with Flu vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Flu vaccine (unknown). At an unspecified time after vaccination with Flu vaccine, the subject experienced Guillain Barre Syndrome. The subject was hospitalised. At the time of reporting the outcome of the Guillain Barre Syndrome was unspecified. The consumer reported that she knew of a male subject that received a flu vaccine (unknown manufacturer) an unspecified number of years ago and was diagnosed with Guillain Barre syndrome. The consumer reported that the subject was placed in intensive care unit in the hospital. The consumer did not want to provide any additional information and did not want any further contact. This was one of two cases reported by this consumer; see case A0811643A, for an additional report of a subject experiencing Guillain Barre Syndrome after receiving a flu shot vaccine.
Red, raised firm area on right thigh. Father reports intermittent vomiting. No fever. Vaccines administered 5/31/13, office visit 6/11/13. Treatment: Comfort measures including TYLENOL.
I had the same events almost everyone did, small heache and some ache in the arm with the first shot, 2nd shot I had a high fever (when it broke it was 101 so it was much higher than that) aches, chills, 30 hours in bed couldnt move. My concern is now is has been just about two months and i received the same symptoms out of the blue that i previously experienced. 30 hours of 101.4 fever, aches, chills, couldnt move out of bed....Why? this couldnt be a coincidence, why after 2 months almost to the date did i get the same symptoms back again? and apparently I am not the only one, I beginning to hear more and more people saying the same thing...why?
Patient was given Pfizer 12+ vaccine verses Pfizer 5-11yr old.  Patient waited the full 15 min after administering vaccine, the patient did not verbalize any adverse symptoms at this time.
Patient was found in her bed, she had vomited. Was lethargic and unresponsive.  Temp was 105.7.  No difficulty breathing. Not able to sit or raise her head.
Two weeks after receiving the third dose (booster) of the COVID vaccine, red spots (rash) have appeared all over my body, which are very itchy. I take BENADRYL allergy pills and it gives me great relief while it lasts.
Itchy, red elevated vaccine site. Not painful. Cool compresses and BENADRYL.